Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Geriatr Oncol. 2018 Dec 13;10(2):317–321. doi: 10.1016/j.jgo.2018.11.008

Table 2:

Correlational Analyses

Dominant hand
grip strength
(n=71)
Non-dominant
hand grip strength
(n=71)
Timed get up and
go
(n=102)
Age −.12 −.24* .21*
Marriage .12 .19 −.28*
Education .23 .12 −.23*
Race .08 .10 .29*
Time since surgery .12 .11 −.07
Time on current meds .07 −.01 .02
Time on any meds .20 .13 −.08
Tamoxifen vs Aromatase inhibitors −.21 −.05 .09
Surgery Type −.04 .06 −.19
TNM Stage −.09 −.06 −.06
Comorbidity (ACE scale) −.06 −.12 .36*
Fatigue (BFI) −.21 −.26* .21*
Pain Intensity (BPI) −.30* −.31* .38*
Vasomotor symptoms (MENQOL) −.14 −.23 .03
Neurotoxicity (FACT-T) −.25* −.23 .11
Symptom Composite (Z score) −.29* −.34* .24*

Note: The following dummy codes were used in analyses: Marriage: 0=Unmarried, 1=Married; Race: 0=White, 1=Non-White; Surgery type: 0=Lumpectomy, 1=Mastectomy; Tam vs. AI: 0=Tamoxifen, 1=AI.

*

p < 0.05